Fundraising Fox

SentreHeart

Redwood City, US · Delaware corporation · 2 known investors

sentreheart.com ↗

SentreHeart appears to now redirect to AtriCure, Inc., a medical device company. Its content references products such as the cryoXT probe for reducing residual limb pain related to amputation.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

RSRussell Seiber
Russell SeiberExecutive
PS
Pam SimonsExecutive
GF
Greg FungExecutive
RS
Robert StrasserExecutive

Board

PYPhil Young
Phil YounginBoard directorSenior Advisor at US Venture Partners
VT
Victor TongBoard director
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
RH
Russell HirschBoard directorManaging Director at Prospect Venture Partners
TH
Theodore HuberBoard director
SH
Steven HochbergBoard director
RF
Richard FerrariBoard director
CY
Chen YuBoard director

Investors · 2

Prospect Venture PartnersMenlo Park · $3M – $5Mvia Russell Hirsch · led
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board

Reported raises · per SEC filings

Form D private placements

$25M disclosed across 1 round · 2016

▶$25MraisedOct 2016 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil YoungDirector
  • Victor TongDirector
  • Casey TanseyDirector
  • Russell HirschDirector
  • Russell SeiberExecutive Officer, Director
  • Theodore HuberDirector
  • Pam SimonsExecutive Officer
  • Greg FungExecutive Officer
  • Steven HochbergDirector
  • Richard FerrariDirector
  • Chen YuDirector
  • Robert StrasserExecutive Officer
Offering amount
$35M
Amount sold
$25M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

SentreHeart locks down $35M in Series D round for atrial fibrillation device | Fierce Biotechfiercebiotech.com · Sep 2016

Frequently asked questions

What does SentreHeart do?
SentreHeart appears to now redirect to AtriCure, Inc., a medical device company. Its content references products such as the cryoXT probe for reducing residual limb pain related to amputation.
Who are SentreHeart's investors?
SentreHeart's investors include Prospect Venture Partners, US Venture Partners.
How much funding has SentreHeart raised?
SentreHeart has disclosed $25M raised across 1 round.
Where is SentreHeart headquartered?
SentreHeart is headquartered in Redwood City, US.